Evidence map›Paper›PMID 26730358›Full record

ArticleJournal of bone oncology2015

Incidence of distal bone metastases in patients treated for palliative radiotherapy and associations with primary tumour types.

Mark Barnes, Manpreet S Tiwana, Andrew Kiraly, Mitch Hutchison, Robert A Olson

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of bone oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mark BarnesBC Cancer Agency-Centre for the North, 1215 Lethbridge Street, Prince George, BC, Canada V2M7E9.
Manpreet S TiwanaBC Cancer Agency-Centre for the North, 1215 Lethbridge Street, Prince George, BC, Canada V2M7E9; University of Northern BC 333 University way, Prince George, BC, Canada V2N4Z9.
Andrew KiralyUniversity of Northern BC 333 University way, Prince George, BC, Canada V2N4Z9.
Mitch HutchisonBC Cancer Agency-Centre for the North, 1215 Lethbridge Street, Prince George, BC, Canada V2M7E9.
Robert A OlsonBC Cancer Agency-Centre for the North, 1215 Lethbridge Street, Prince George, BC, Canada V2M7E9; University of Northern BC 333 University way, Prince George, BC, Canada V2N4Z9; University of British Columbia Radiation Oncologist, BC Cancer Agency-Centre for the North, 1215 Lethbridge Street, Prince George, BC, Canada V2M7E9.
BC Cancer Agency · CAUniversity of Northern British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study assesses the incidence of distal bone metastases in palliative radiotherapy (RT) patients. MATERIAL AND

methodsAll courses of RT for bone metastases from 2007-2011 for patient living in British Columbia (BC) were identified in a provincial RT programme. Treated bone metastases (BoM) were categorized as distal if the BoM was located within or distal to the elbow or knee. Patients were grouped by primary tumour site as breast, lung, prostate gastrointestinal, haematological, melanoma, and other. The incidence of distal bone metastases and associations with primary tumour types were determined.

resultsFrom 2007 to 2011, 8008 patients were treated with 16,277 courses of RT, of which 425 (3%) were courses of RT for distal BoM. The incidence of distal BoM in decreasing order by primary tumour type was melanoma (5%), haematological (3%), lung (2%), other (2%), prostate (2%), breast (1%) and gastrointestinal (1%). Distal BoM where more commonly identified in the lower extremity (87%, p<0.001). Single fraction RT was used more commonly for distal vs non-distal BoM (66% vs. 49%; p<0.001).

conclusionThe incidence of distal BoM among patients treated with palliative RT was 3% and most commonly identified in patients with melanoma and haematological malignancies.

Indexed as

Bone metastasesMultiple fractionsPalliative radiotherapySingle fraction

Identifiers

PMID26730358
PMCPMC4678776
OpenAlexW1896613973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.